| Citation: |
HAO Xiang-rong, HU Tao, YANG De-chun, WANG Ya-li. Application of multiple sites combined with anti-inflammatory therapy in stable stage of chronic obstruct pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2012, (17): 133-134,137.
|
|
中华医学会呼吸病学分会, 慢性阻塞性肺疾病学组. 阻塞性肺疾病诊治指南(2007年修订版) [J]. 中华结核和呼吸杂志, 2007(1):254.
|
|
Gan W Q, Man S F, Senthilselvan A. Association between chronic obstructive pulmonary disease and systemic inflammation a systematic review and a metaanalysis [J]. Thorax, 2004(7):574.
|
|
雷蕾, 吴昌归, 张亮. 布地奈德在慢性阻塞性肺疾病急性加重期的临床疗效观察 [J]. 实用临床医药杂志, 2010, (23):14.doi: 10.3969/j.issn.1672-2353.2010.23.005.
|
|
邹春芳. 舒利迭和顺尔宁联合应用对COPD肺功能的影响 [J]. 临床肺科杂志, 2009(8):1032.doi: 10.3969/j.issn.1009-6663.2009.08.021.
|
|
钟慧, 洪建国. 半胱氨酰白三烯受体拮抗剂孟鲁司特的研究进展 [J]. 国际呼吸杂志, 2011, (19):1492.doi: 10.3760/cma.j.issn.1673-436X.2011.019.014.
|
|
银春, 冯玉麟. 茶碱的作用机制及在慢性阻塞性肺疾病中的应用 [J]. 临床肺科杂志, 2008(7):885.doi: 10.3969/j.issn.1009-6663.2008.07.034.
|
|
Vernooy J H, Drummen N E, van Suylen R J. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers [J]. Thorax, 2009(1):26.
|
|
Bircan A, Gokirmak M, Kilic O. C-reactive protein levelsin patients with chronic obstructive pulmonary disease:role ofinfection [J]. Medical Principles and Practice, 2008(3):202.
|
|
金雪梅, 李晓佳. 辛伐他汀治疗慢性阻塞性肺疾病患者疗效观察 [J]. 临床肺科杂志, 2008(7):1012.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: